STUPEFIX: Externalization and Stimulation
Study Details
Study Description
Brief Summary
The distinction between self-generated and external information is impaired in patients with schizophrenia, who are assumed to confuse imagination with real perceptions. To better understand the underlying mechanisms of these abnormalities, the investigator will investigate the brain mechanisms supporting auditory externalization. Auditory externalization is the ability to perceive whether a sound comes from inside or outside oneself. Our study, in healthy participants, will use functional brain imaging to identify the brain areas involved in the externalization of sound sources and to test whether neuromodulation of this area can modify this ability and provide a therapeutic lead in pathological populations
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
30 healthy participants will be included. The participants will undergo three separate visits. During the first one, the participants will listen to sounds coming from either internal or external sources while undergoing an fMRI session. This will allow us to identify the brain region involved in externalizing abilities with the highest activity. In the second and third visits, this specific region will be targeted by HD-tDCS (a non-invasive high-definition neuromodulation technique whose precision is enhanced by individual data) to modulate its activity and test its causal involvement in externalization processes. Each participant will receive both active and placebo stimulation, with the order counterbalanced. During the stimulation, participants will complete an externalization task, followed by a reality monitoring task and a self-agency task. Additionally, the investigator will gather socio-demographic and psychometric data.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: 15 healthy participants active then placebo 15 healthy participants will receive a session of active HD-tDCS and then a session of placebo HD-tDCS. |
Procedure: High-definition transcranial direct current (HD-tDCS), active condition
Participants will receive a session of active HD-tDCS at a current intensity of 2 mA for a duration of 25min. The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI. During the stimulation, participants will be engaged in a computer-based externalization task.
Procedure: High-definition transcranial direct current (HD-tDCS), placebo condition
Participants will receive a session of placebo HD-tDCS, which will be delivered following the same procedures as active HD-tDCS but the intensity of the current will be set at 2mA during the 30 first seconds at the beginning of the 25-min period of the stimulation, and equal to 0 mA for the reminding period of stimulation to simulate the tingling sensation often experienced by individuals during active stimulation.
The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI. During the stimulation, participants will be engaged in a computer-based externalization task
|
| Placebo Comparator: 15 healthy participants placebo then active 15 healthy participants will receive a session of placebo HD-tDCS and then a session of active HD-tDCS. |
Procedure: High-definition transcranial direct current (HD-tDCS), active condition
Participants will receive a session of active HD-tDCS at a current intensity of 2 mA for a duration of 25min. The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI. During the stimulation, participants will be engaged in a computer-based externalization task.
Procedure: High-definition transcranial direct current (HD-tDCS), placebo condition
Participants will receive a session of placebo HD-tDCS, which will be delivered following the same procedures as active HD-tDCS but the intensity of the current will be set at 2mA during the 30 first seconds at the beginning of the 25-min period of the stimulation, and equal to 0 mA for the reminding period of stimulation to simulate the tingling sensation often experienced by individuals during active stimulation.
The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI. During the stimulation, participants will be engaged in a computer-based externalization task
|
Outcome Measures
Primary Outcome Measures
- Externalization abilities [one year]
proportion of sounds perceived as coming from an external source in the externalization task (range 0-100%)
Secondary Outcome Measures
- Reality monitoring performance [one year]
Scores obtained at the reality monitoring task (Brunelin et al., 2006) (accuracy, range = 0-100%)
- Self-agency [one year]
Percentage of voice deviation in the self-agency task (Subramaniam et al., 2018) (pitch perturbation and variability in peak deviation in cents, cents(t) = 1200 log2 (Hertz(t )/HertzRef), mean pitch perturbation response tracks = ±100 and ± 400)
- Psychometric characteristics that may influence externalization abilities and stimulation effects [baseline]
Launay-Slade Hallucinations Scale scores between 0 and 64 (LSHS; Launay and Slade)
- Psychometric characteristics that may influence externalization abilities and stimulation effects [baseline]
Plymouth Sensory Imagery Questionnaire (PSIQ).Scores between 0 and 70.
- Side effects of stimulation [1 time before (baseline) and within 1 hour after stimulation]
Scores at the questionnaire on side effects of stimulation. Scores between 10 and 44 (higher scores mean worse outcome)
- Mood [1 time before (baseline) and within 1 hour after stimulation]
Mood self-questionnaire. Scores between 0 and 100 (higher scores mean worse outcome)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Having given their written informed consent
-
Affiliated with a social security scheme
-
French speakers and readers
Exclusion Criteria:
-
With contraindication to HD-tDCS stimulation or fMRI
-
With a history of or current hearing problems, including tinnitus
-
Taking medication (except contraceptives)
-
With a history of or current psychiatric diagnosis (DSM-5 criteria)
-
First-degree relatives with a diagnosis of schizophrenia spectrum disorder or bipolar disorder (DSM5)
-
Have a personal history of neurological disorders or head trauma with loss of consciousness
-
With an intellectual disability (Raven's Matrices)
-
With developed musical abilities (i.e., regular practice of a musical instrument for at least 10 years with assiduity or at a music school or conservatory)
-
Pregnant or nursing
-
Being in a period of exclusion and/or having exceeded the annual indemnity ceiling (€4,500) for other clinical research.
-
Under guardianship
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Centre Hospitalier le Vinatier | Bron | France | 69678 |
Sponsors and Collaborators
- Hôpital le Vinatier
Investigators
- Principal Investigator: Marine MONDINO, Phd, hospital le Vinatier
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2023-A00452-43